Bronx, NY, United States of America

Brian Christopher Wengerter


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Brian Christopher Wengerter

Introduction

Brian Christopher Wengerter, a distinguished inventor based in Bronx, NY, has made significant contributions to the field of medical research through his innovative patents. With two patents to his name, Wengerter has focused on advancing methods for targeted antigen delivery and cancer treatment.

Latest Patents

His latest patents reflect groundbreaking approaches to medical treatment. The first patent, titled "Aptamer-targeted antigen delivery," presents a composition that includes an oligonucleotide aptamer conjugated to an antigen. This aptamer specifically targets cell-surface markers on antigen-presenting cells, offering methods for effectively delivering antigens to dendritic cells and eliciting immune responses in subjects. The second patent, "Methods of preparing targeted aptamer prodrugs," outlines techniques for selectively introducing oligonucleotides and nucleoside analogs into a subject's cells. This invention emphasizes the importance of targeted drug delivery in treating or preventing cancer and viral infections.

Career Highlights

Wengerter is an esteemed member of the team at the Albert Einstein College of Medicine, where he continues to focus on innovative research that has the potential to change the landscape of medical treatments. His dedication to advancing healthcare solutions has garnered him recognition and respect in the research community.

Collaborations

Throughout his career, Wengerter has engaged in collaborations with prominent figures in his field, including colleagues Matthew Levy and Deborah Palliser. These partnerships have contributed to the depth and impact of his research, fostering a collaborative approach to scientific innovation.

Conclusion

Brian Christopher Wengerter exemplifies the spirit of innovation in the medical research community. With his patents aimed at enhancing targeted therapies, he is paving the way for future advancements in the treatment of diseases, including cancer and viral infections. His work not only demonstrates his inventive prowess but also underlines the importance of collaboration in achieving groundbreaking results in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…